Multi-omics reveals Dengzhan Shengmai formulation ameliorates cognitive impairments in D-galactose-induced aging mouse model by regulating CXCL12/CXCR4 and gut microbiota

Dengzhan Shengmai (DZSM), a traditional Chinese medicine formulation, has been administered extensively to elderly individuals with cognitive impairment (CI). However, the underlying mechanisms by which Dengzhan Shengmai improves cognitive impairment remains unknown. This study aimed to elucidate th...

Descripción completa

Detalles Bibliográficos
Autores principales: Hou, Jing-Yi, Xu, He, Cao, Guang-Zhao, Tian, Liang-Liang, Wang, Li-Han, Zhu, Nai-Qiang, Zhang, Jing-Jing, Yang, Hong-Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10123283/
https://www.ncbi.nlm.nih.gov/pubmed/37101548
http://dx.doi.org/10.3389/fphar.2023.1175970

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10123283/
https://www.ncbi.nlm.nih.gov/pubmed/37101548
http://dx.doi.org/10.3389/fphar.2023.1175970

Ejemplares similares